SYS-CON MEDIA Authors: Sean Houghton, Glenn Rossman, Ignacio M. Llorente, Xenia von Wedel, Peter Silva

News Feed Item

Advanced Wound Care: World Market Prospects 2013-2023

NEW YORK, Jan. 3, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Advanced Wound Care: World Market Prospects 2013-2023

http://www.reportlinker.com/p0733754/Advanced-Wound-Care-World-Market-Pr...

Report Details

The demand for advanced wound care products is expected to rise over the next 10 years, driven by an increase in chronic wounds. This can be attributed to an aging population and an increase in lifestyle related disorders such as diabetes and obesity. Visiongain predicts the total advanced wound care market to be worth $16.3bn in 2023.

The move from traditional wound care treatment to advanced wound care started in the mid 80's, with more and more advanced products coming in to the market. Clinicians and patients now prefer advanced wound care products over traditional products, as they are more efficient in wound healing and reduce hospital stays. While moist wound care products currently dominate the market, wound care devices and biologics are witnessing strong growth. More companies, both multinationals and smaller companies are investing in R&D to make their product lines stronger. However, the growth will depend on more clinical evidence becoming available.

Visiongain's report Advanced Wound Care: World Market Prospects 2013-2023 examines the moist wound care, wound care devices and wound care biologics market with respect to the market size and the growth of leading sub segments from 2013-2023. This report also discusses the leading companies operating in this space and promising products in the pipeline. Visiongain predicts that this market will grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices, and increased patient adoption of existing and newly-marketed products. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interviews with experts within the advanced wound care market. There are 115 tables and figures included. Visiongain has determined that the value of the global advanced wound care market will reach $16.3bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 - all highlighting key business opportunities.

Why you should buy Advanced Wound Care: World Market Prospects 2013-2023

• 148 pages of comprehensive analysis• 2 Exclusive Visiongain interviews with experts from-- Derma Sciences- Shire Regenerative Medicine• 115 tables, charts, and graphs• Global advanced wound care market forecast between 2012-2023• 3 advanced wound care submarket forecasts from 2012-2023- Moist Wound Care- Wound Care Devices- Wound Care Biologics• SWOT analysis for each submarket• Several leading companies identified and 6 profiled -- Kinetic Concepts Inc (KCI)- Smith & Nephew (S&N)- Molnlycke Health Care- ConvaTec- Systagenix Wound Management- Coloplast

You can order this report today

Gain an understanding of the overall advanced wound care market and the leading companies operating in this market by ordering Advanced Wound Care: World Market Prospects 2013-2023.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents

1. Executive Summary1.1 Sector Highlights1.2 Aim, Scope and Format of this Report1.3 Chapter Outline1.4 Research and Analysis Method1.5 Glossary of Terms Relating to Advanced Wound Care

2. Introduction

2.1 What is a Wound?

2.2 Wound Classification

2.2.1 Acute Wounds

2.2.2 Chronic Wounds

2.2.2.1 The Increasing Prevalence of Chronic Wounds

2.2.3 Burns

2.3 The Skin

2.4 The Phases of Wound Healing

2.4.1 The Inflammatory Phase

2.4.2 The Proliferation Phase

2.4.3 The Fibroblastic Phase

2.4.4 The Maturation Phase

2.5 Wound Care

2.5.1 Role of Wound Dressing

2.6 The History of Wound Care

2.7 Wound Care Categories

2.7.1 Traditional Wound Care

2.7.1.1 Gauze Dressings

2.7.1.2 Absorptive Dressings

2.7.1.3 Composite Dressings

2.7.1.4 Compression Therapy

2.7.1.5 Contact Layers

2.7.2 Advanced Wound Care (AWC)

2.7.2.1 Moist Wound Care (MWC)

2.7.2.1.1 Hydrocolloid Dressings

2.7.2.1.2 Foam Dressings

2.7.2.1.3 Alginate Dressings

2.7.2.1.4 Hydrogel Dressings

2.7.2.2 Wound Care Devices

2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)

2.7.2.2.2 Ultrasound for wound therapy

2.7.2.3 Wound Care Biologics

2.7.2.3.1 Skin Replacement Therapies

2.7.2.3.2 Collagen Based Therapies

2.7.2.3.3 Cell Based Therapies

2.8 Regulation of Medical Devices

2.8.1 The US Regulation System

2.8.2 The European Approval and Regulation Process

3. Global Advanced Wound Care Market, 2011-20233.1 The Global Medical Devices Market, 20113.2 Global Wound Care Market, 20113.2.1 Global Wound Care Market Trends, 20113.2.2 Advanced Wound Care Market, 20113.3 Global Advanced Wound Care Market Forecast, 2012-20233.3.1 Global Advanced Wound Care Market Trends, 2012-2023

4. The Moist Wound Care Market, 2011-2023

4.1 The Moist Wound Care Market: Overview

4.2 The Moist Wound Care Market, 2011

4.3 Moist Wound Care Market Forecast, 2012-2023

4.4 The Moist Wound Care Market Segments, 2011

4.4.1 The Hydrocolloid Dressings Market

4.4.2 The Foam Dressings Market

4.4.3 The Alginate Dressings Market

4.4.4 The Hydrogel Dressings Market

4.4.5 Other MWC Dressings Market

4.4.5.1 Hydrofiber Technology, ConvaTec

4.4.5.2 Tegaderm Matrix Dressing with PHI Technology, 3M

4.4.5.3 XTRASORB, Derma Sciences

4.4.5.4 Lipido-Colloidal Technology Dressings, URGO MEDICAL

4.4.5.5 Antimicrobial Dressings

4.5 The Moist Wound Care Pipeline, 2011

4.5.1 NanoDOX, Nanotherapeutics

4.5.2 '1' Primary Wound Dressing, Phytoceuticals

4.6 SWOT Analysis of the Moist Wound Care Market, 2012-2023

4.6.1 Strengths

4.6.1.1 Established Segment of the Market

4.6.1.2 Wide Variety of Products

4.6.1.3 More Effective than Traditional Wound Care

4.6.2 Weaknesses

4.6.2.1 Less Effective than Some Devices and Biologics

4.6.2.2 Weak R&D Pipeline

4.6.3 Opportunities

4.6.3.1 Increasing Prevalence of Chronic Wounds

4.6.3.2 Cheap Alternative to Devices and Biologics

4.6.4 Threats

4.6.4.1 Emerging Technologies May be More Effective

4.6.4.2 Lack of R&D Spending will Stifle Innovation

5. Wound Care Devices Market, 2011-20235.1 Wound Care Devices Market: Overview5.2 The Wound Care Devices Market, 20115.3 The Wound Care Devices Forecast, 2012-20235.3.1 Wound Care Devices Market, 2012-20175.3.2 Wound Care Devices Market, 2017-20235.4 The NPWT Market5.4.1 The NPWT Market, 20115.4.2 Leading NPWT Devices: Product Analysis5.4.2.1 V.A.C. Therapy (KCI)5.4.2.2 RENASYS Systems (Smith & Nephew)5.4.3 Other NPWT Systems, 20115.4.4 The NPWT Market Forecast, 2012-20175.4.5 The NPWT Market Forecast, 2017-20235.5 Ultrasound Wound Therapy Market, 20115.6 Other Wound Care Devices, 20115.6.1 Electrical Stimulation5.6.2 Extracorporeal Shock Wave Therapy5.7 The Wound Care Devices Pipeline5.7.1 dermaPACE, Sanuwave Health5.7.2 O-ACE-Sys (Ingenious Technologies Corporation)5.7.3 Red Light Wave Therapy (Lightwave Technologies)5.8 SWOT Analysis of the Wound Care Devices Market, 2012-20235.8.1 Strengths5.8.1.1 More Effective than Other Forms of Wound Care5.8.1.2 Constant Innovation in the Market5.8.2 Weaknesses5.8.2.1 Dominated by Few Large Companies5.8.2.2 NPWT Dominates the Market5.8.3 Opportunities5.8.3.1 Low Cost NPWT Systems will Drive Growth5.8.3.2 Increasing Prevalence of Chronic Wounds5.8.4 Threats5.8.4.1 Controversy Regarding Safety of NPWT5.8.4.2 Ongoing Legal Battles Threaten Innovation

6. Wound Care Biologics Market, 2011-2023

6.1 Wound Care Biologics Market: Overview

6.2 Wound Care Biologics Market, 2011

6.3 The Wound Care Biologics Market Forecast, 2012-2023

6.3.1 Drivers and Restraints, 2012-2023

6.4 The Skin Replacement Market

6.4.1 The Skin Replacement Market, 2011

6.4.2 Leading Products in the Skin Replacement Market, 2011

6.4.2.1 Dermagraft, Shire Regenerative Medicine

6.4.2.2 Apligraf, Organogenesis

6.4.3 New Technologies

6.4.3.1 Spray on Skin to Treat Venous Leg Ulcers

6.4.4 Other Leading Products, 2011

6.4.5 The Skin Replacement Market Forecast, 2011-2017

6.4.6 The Skin Replacement Market Forecast, 2017-2023

6.5 Collagen Based Therapy Market

6.5.1 Collagen Based Therapy Market, 2011

6.5.2 The Collagen Based Therapy Market Forecast, 2011-2017

6.5.3 The Collagen Based Therapy Market Forecast, 2017-2023

6.6 The Cell Therapy Market

6.6.1 The Cell Therapy Market, 2011

6.6.2 The Cell Therapy Market Forecast, 2011-2017

6.6.3 The Cell Therapy Market Forecast, 2017-2023

6.7 The Biologics Pipeline

6.7.1 Stem Cells

6.7.1.1 Stem Cell Skin Gun, McGowan Institute for Regenerative Medicine at the University of Pittsburgh

6.7.1.2 Adult Stem Cells, Cryo-Cell International and the Snyder Wound Research Institute

6.7.1.3 Mesenchymal Stem Cells, Nara University, Japan

6.7.2 Artificial Skin

6.7.2.1 e-Skin, UC Berkeley

6.7.2.2 Genetically Modified Artificial Skin, University of Cincinnati

6.7.2.3 ReCell, Avita Medical

6.7.3 Automated Artificial Skin Production

6.7.3.1 The Tissue Factory, Fraunhofer Institute

6.7.4 Nanotechnology

6.7.4.1 DermaFuse, Missouri S&T and Mo-Sci Corporation

6.7.4.2 Phytochemical Tissue Bonding, Harvard University Institute of Photomedicine

6.7.4.3 Giant Unilamellar Vesicles, University of Bath

6.7.5 Collagen Based Therapy

6.7.5.1 Artificial Collagen Based Wound Care (Cornell University)

6.8 SWOT Analysis of the Wound Care Biologics Market, 2012-2023

6.8.1 Strengths

6.8.1.1 More Effective than Other Forms of Wound Care

6.8.1.2 New Technology with Constant Innovation

6.8.1.3 Strong R&D Pipeline

6.8.2 Weaknesses

6.8.2.1 Small Start-up Companies Dominate the Market

6.8.2.2 Expensive Technology

6.8.2.3 High Barriers to Entry

6.8.3 Opportunities

6.8.3.1 Strong Innovation will Drive Growth

6.8.3.2 Stem Cells Offer Multiple Opportunities

6.8.3.3 Increasing Prevalence of Chronic Wounds

6.8.3.4 Development of Diagnostic Tests

6.8.4 Threats

6.8.4.1 Controversy Regarding the Effectiveness of Some Biologics

6.8.4.2 High Barriers to Entry will Deter Competitors

6.8.4.3 Competition from MWC and Devices

7. Leading National Advanced Wound Care Market, 2011-20237.1 Regional Breakdown of the Global Advanced Wound Care Market, 20117.2 The Global Advanced Wound Care Market: Regional Forecast, 2012-20237.3 The US Market7.4 The European Market7.4.1 Germany and France7.4.2 The UK Market7.4.3 The Spanish Market7.4.4 The Italian Market7.5 The Japanese Market7.6 The Chinese Market7.7 The Indian Market

8. Leading Companies in Advanced Wound Care Market, 2012-2023

8.1 Leading Companies, 2011

8.2 Kinetic Concepts Inc (KCI)

8.2.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn

8.2.2 Success of VAC Therapy

8.2.3 KCI Expands its Operations

8.3 Smith & Nephew (S&N)

8.3.1 Sales and Performance Analysis, 2011

8.3.2 Regional Breakdown, 2011

8.3.3 Smith & Nephew Advanced Wound Care Sales. 2011

8.3.4 Advanced Wound Management Sales by Region, 2011

8.3.5 Smith & Nephew Pipeline

8.3.6 Smith & Nephew Acquires Kalypto Medical

8.4 Molnlycke Health Care

8.4.1 Molnlycke Sales, 2011

8.4.2 Recent Acquisitions

8.4.2.1 Molnlycke Acquires WoundEL from Gerromed GmbH

8.4.2.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical

8.5 ConvaTec

8.5.1 Sales and Performance Analysis, 2011

8.5.2 ConvaTec Advanced Wound Care Sales, 2011

8.5.3 Regional Breakdown, 2011

8.5.4 ConvaTec Research & Development

8.6 Systagenix Wound Management

8.6.1 Systagenix Acquires O2 Insights Inc

8.7 Coloplast

8.7.1 Coloplast Sales and Performance Analysis, 2011

8.7.2 Regional Breakdown, 2011

8.7.3 Coloplast Advanced Wound Care Sales, 2010/2011

8.8 Other Companies, 2011

9. Expert Opinion9.1 Interview with Derma Sciences9.1.1 Perspective of Advanced Wound Care Market9.1.2 Unmet needs of the Industry9.1.3 Do FDA Regulations Stifle Innovation?9.1.4 Role of Moist Wound Care in the Future9.1.5 Market for MEDIHONEY in Moist Wound Care9.1.6 Key Products Driving Company Growth9.1.7 Efficacy of Honey in Comparison to Silver9.2 Interview with Shire Regenerative Medicine9.2.1 Perspective of Wound Care Biologics Market9.2.2 Cost and Reimbursement Issues9.2.3 Outlook for Dermagraft

10. Advanced Wound Care Market, 2012-2023

10.1 Advanced Wound Care Market, 2012-2023

10.1.1 Growth will be driven by an Increasing Prevalence of Chronic Wounds

10.1.2 Emerging Markets will Drive Growth

10.2 The Moist Wound Care Market

10.3 The Wound Care Devices Market

10.4 The Wound Care Biologics Market

List of Tables

Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification SystemTable 2.2 The Classification of Burns by Depth: Degree Classification SystemTable 2.3 The Classification of Burns by SeverityTable 2.4 The Advantages and Disadvantages of Moist Wound CareTable 2.5 The Benefits and Risks of Skin GraftingTable 3.1 Medical Device Market: Global Revenue ($bn) and Market Shares (%) by Sector, 2011Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Shares (%) by Sector, 2011Table 3.3 The Advanced Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2011Table 3.4 The Advanced Wound Care Market Forecast ($bn, %), 2011-2023Table 3.5 Drivers and Restraints for the Advanced Wound Care Market, 2012-2023Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Share (%) by Segments, 2011Table 4.2 The Moist Wound Care Market Forecast ($bn, %), 2011-2017Table 4.3 The Moist Wound Care Market Forecast ($bn, %), 2017-2023Table 4.4 Leading Products in Hydrocolloid Dressing Market, 2011Table 4.5 Leading Products in the Foam Dressing Market, 2011Table 4.6 Leading Products in the Alginate Dressing Market, 2011Table 4.7 Leading Products in the Hydrogel Dressing Market, 2011Table 4.8 Moist Wound Care Products Pipeline, 2011Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2012-2023Table 5.1 The Wound Care Device Market: Revenue ($bn) and Market Share (%) by Segments, 2011Table 5.2 The Wound Care Devices Market Forecast ($bn, %), 2011-2017Table 5.3 The Wound Care Devices Market Forecast ($bn, %), 2017-2023Table 5.4 The NPWT Market Forecast ($bn, %), 2011-2017Table 5.5 The NPWT Market Forecast ($bn, %), 2017-2023Table 5.6 Drivers and Restraints in the NPWT Market, 2012-2023Table 5.7 Leading Products in the Ultrasound Wound Therapy Market, 2011Table 5.8 Leading Products in the Electrical Stimulation Market, 2011Table 5.9 Wound Care Devices Development Pipeline, 2011Table 5.10 SWOT Analysis of the Wound Care Devices Market, 2012-2023Table 6.1 The Wound Care Biologics Market: Revenue ($bn) and Market Shares (%) by Segments, 2011Table 6.2 The Wound Care Biologics Market Forecast ($bn, %), 2011-2017Table 6.3 The Wound Care Biologics Market Forecast ($bn, %), 2017-2023Table 6.4 Drivers and Restraints in the Biologics Market, 2012-2023Table 6.5 Other Leading Products in the Skin Replacement Market, 2011Table 6.6 The Skin Replacement Market Forecast ($bn, %), 2011-2017Table 6.7 The Skin Replacement Market Forecast ($bn, %), 2017-2023Table 6.8 Leading Products in the Collagen Based Therapy Market, 2011Table 6.9 The Collagen Based Therapy Market Forecast ($bn, %), 2011-2017Table 6.10 The Collagen Based Therapy Market Forecast ($bn, %), 2017-2023Table 6.11 Leading Products in the Cell Therapy Market, 2011Table 6.12 The Cell Therapy Market Forecast ($bn, %), 2011-2017Table 6.13 The Cell Therapy Market Forecast ($bn, %), 2017-2023Table 6.14 Other Leading Biologic Products in the Market, 2011Table 6.15 The Wound Care Biologics Development Pipeline, 2011Table 6.16 SWOT Analysis of the Wound Care Biologics Market, 2012-2023Table 7.1 Leading National Markets for Advanced Wound Care ($bn) and Market Shares (%), 2011Table 7.2 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2017Table 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2017-2023Table 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011Table 7.5 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2011-2017Table 7.6 The European Advanced Wound Care Market Forecast ($bn, %) by leading Countries 2017-2023Table 7.7 Chinese Advanced Wound Care Market: Drivers and Restraints, 2012-2023Table 8.1 Leading Companies in the AWC Market: Revenue ($bn) and Market Shares (%), 2011Table 8.2 VAC Therapy at a Glance, 2011Table 8.3 Smith & Nephew Revenue ($bn) and Market Shares (%) by Business Segments, 2011Table 8.4 Smith & Nephew Market Shares (%) by Region, 2011Table 8.5 Smith & Nephew Advanced Wound Management Sales ($bn) by Region, 2011Table 8.6 ConvaTec: Revenue ($m) and Market Share (%) by Business Segments, 2011Table 8.7 ConvaTec Sales ($m) by Region, Revenue ($m) and Market Shares (%) 2011Table 8.8 Coloplast: Revenue ($bn) and Market Share (%) by Segments, 2010/2011Table 8.9 Coloplast Sales ($bn) by Region, 2010/2011Table 8.10 Other Companies in Advanced Wound Care Market, 2011Table 10.1 Global Advanced Wound Care Market: Drivers and Restraints, 2012-2023

List of Figures

Figure 2.1 The Phases of Wound Healing and Duration (Days)

Figure 3.1 Medical Device Market: Global Revenue ($bn) by Sector, 2011

Figure 3.2 Medical Device Market: Market Share(%) by Sector, 2011

Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2011

Figure 3.4 Global Wound Care Market: Market Shares (%) by Sector, 2011

Figure 3.5 The Advanced Wound Care Market: Revenue ($bn) by Segment, 2011

Figure 3.6 The Advanced Wound Care Market: Market Share (%) by Segment, 2011

Figure 3.7 The Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 4.1 The Moist Wound Care Market: Revenue ($bn) by Segments, 2011

Figure 4.2 The Moist Wound Care Market: Market Share (%) by Segments, 2011

Figure 4.3 Total Moist Wound Care Market Forecast ($bn), 2011-2023

Figure 5.1 The Wound Care Devices: Revenue ($bn) by Segments, 2011

Figure 5.2 The Wound Care Devices: Market Share (%) by Segments, 2011

Figure 5.3 Total Wound Care Devices Market Forecast ($bn), 2011-2023

Figure 5.4 NPWT Wound Therapy Devices Market Forecast ($bn), 2011-2023

Figure 5.5 Ultrasound Wound Therapy Market Forecast ($bn), 2011-2023

Figure 5.6 The NPWT Market Forecast: Revenue ($bn), 2011-2017

Figure 5.7 The NPWT Market Forecast ($bn), 2017-2023

Figure 6.1 The Wound Care Biologics Market: Revenue ($bn) by Segments, 2011

Figure 6.2 The Wound Care Biologics Market: Market Shares (%) by Segments, 2011

Figure 6.3 The Biologics Market Forecast ($bn), 2011-2023

Figure 6.4 The Skin Replacement Market Forecast ($bn), 2011-2017

Figure 6.5 The Skin Replacement Market Forecast ($bn), 2017-2023

Figure 6.6 The Collagen Based Therapy Market Forecast ($bn), 2011-2017

Figure 6.7 The Collagen Based Therapy Market Forecast ($bn), 2017-2023

Figure 6.8 The Cell Therapy Market Forecast ($bn), 2011-2017

Figure 6.9 The Cell Therapy Market Forecast ($bn), 2017-2023

Figure 7.1 The Advanced Wound Care Market: Revenue ($bn) in Leading National Markets, 2011

Figure 7.2 The Advanced Wound Care Market: Market Shares (%) in Leading National Markets, 2011

Figure 7.3 The Advanced Wound Care Market Forecast ($bn, %) by Leading National Markets, 2011-2023

Figure 7.4 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011

Figure 7.5 The Leading European Advanced Wound Care National Markets: Revenue ($bn) and Market Shares (%), 2011

Figure 7.6 The European Advanced Wound Care Market Forecast ($bn) 2011-2023

Figure 7.7 The Advanced Wound Care Market Forecast ($bn) in Germany & France, 2011-2023

Figure 7.8 UK Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.9 Spanish Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.10 Italian Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.11 Japanese Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.12 Chinese Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 7.13 Indian Advanced Wound Care Market Forecast ($bn), 2011-2023

Figure 8.1 Leading Companies in the AWC Market: Revenue ($bn), 2011

Figure 8.2 Leading Companies in the AWC Market: Market Shares (%), 2011

Figure 8.3 Smith & Nephew: Revenue ($bn) by Segments, 2011

Figure 8.4 Smith & Nephew: Market Shares (%) by Segments, 2011

Figure 8.5 Smith & Nephew: Market Shares (%) by Region, 2011

Figure 8.6 Smith & Nephew Advanced Wound Management Sales: Market Share (%) by Region, 2011

Figure 8.7 ConvaTec: Market Share (%) by Business Segment, 2011

Figure 8.8 ConvaTec: Revenue ($m) by Business Segment, 2011

Figure 8.9 ConvaTec Market Shares (%) by Region, 2011

Figure 8.10 Coloplast: Revenue ($bn) by Segments, 2010/2011

Figure 8.11 Coloplast: Market Share (%) by Segments, 2011/2012

Figure 8.12 Coloplast Market Share (%) by Region, 2010/2011

Companies Listed

3MAcellAcryMedActiva Health CareAdvanced Medical SolutionsAgennixAnika TherapeuticsAOTIArgentum MedicalArjoHuntleighArmed Forces Institute of Regenerative Medicine (AFIRM)Arobella MedicalAvita MedicalBiofisicaBiolight ABB.BraunBoehringer IngelheimBrennen MedicalBSN Medical GmbhCardium TherapeuticsCatrixCellerationCentre for Devices and Radiological Health (CDRH)Collagen MatrixColoplastConvaTecCornell UniversityCovalon TechnologiesCovidienCuratecCurasanCytomedixDerma SciencesDeroyalDevon Medical ProductsDiapulse Corporation of AmericaDr. Suwelack Skin & Healthcare Dow-HickamEucare PharmaceuticalsFerrisFibrogenFidia Advanced BiopolymersFood and Drug Administration (FDA) Forticell BioscienceFraunhofer InstituteGarnet BiotherapeuticsGenadyne BiotechnologiesGenzyme BiosurgeryGetingeGreystone PharmaceuticalsHartmann GroupHealthpoint BiotherapeuticsHemCon Medical TechnologiesHollister Wound CareHuman BiosciencesHydroFeraInnovative TherapiesIngenious Technologies CorporationIntegra Life Science CorpInternational Diabetic Federation (IDF)InnocollItalian National Health Service IYIA TechnologiesJohnson & JohnsonKaken PharmaceuticalsKalypto MedicalKinetic ConceptsKuros BiosurgeryLifecellLightwave TechnologiesLescardenLohmann & RauscherMacrocureMarine Polymer Technologies IncMcGowan Institute for Regenerative Medicine Medestea InternazionaleMediWoundMedline IndustriesMiMedXMinistry of Health, Labour and Welfare (MHLW)MisonixMissouri S&T and Mo-Sci CorporationMolnlyckeNara University, JapanNational Competent Authorities (NCA)National Health Service (NHS)NanotherapeuticsNanoVibronixNoble BiomaterialsOculus Innovative SciencesOrganogenesisOsiris TherapeuticsOxygen BiotherapeuticsPhytoceuticalsPolyhealPolynovo BiomaterialsPromethean LifeSciencesProsperaQuick Med TechnologiesRedDressRegeneRx BiopharmaceuticalsRegenesis BiomedicalSafeBlood TechnologiesSangui BioTech InternationalSanuwave HealthShire Regenerative Medicine Smith & NephewSoringSpiracurSynapse MicrocurrentSnyder Wound Research LLCSystagenixTalley GroupTissue GenesisTissue Regeneration TechnologiesUC, BerkleyUDL LaboratoriesULURUUnited Nations (UN)University of CincinnatiUniversity of BathURGOVibrant MedicalVarioVomaris InnovationsWellman Centre for Photomedicine, Harvard University Wound Management TechnologiesWright Medical

To order this report:Medical_Equipment_and_Supply Industry: Advanced Wound Care: World Market Prospects 2013-2023

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete...
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy architecture and infrastructure into account. Then the reality is that most enterprises are embarking on a hybrid cloud strategy and programs. In this Power Panel at 15th Cloud Expo (http://www.CloudComputingExpo.com...
Verizon Enterprise Solutions is simplifying the cloud-purchasing experience for its clients, with the launch of Verizon Cloud Marketplace, a key foundational component of the company's robust ecosystem of enterprise-class technologies. The online storefront will initially feature pre-built cloud-based services from AppDynamics, Hitachi Data Systems, Juniper Networks, PfSense and Tervela. Available globally to enterprises using Verizon Cloud, Verizon Cloud Marketplace provides a one-stop shop fo...
The cloud is becoming the de-facto way for enterprises to leverage common infrastructure while innovating and one of the biggest obstacles facing public cloud computing is security. In his session at 15th Cloud Expo, Jeff Aliber, a global marketing executive at Verizon, discussed how the best place for web security is in the cloud. Benefits include: Functions as the first layer of defense Easy operation –CNAME change Implement an integrated solution Best architecture for addressing network-l...
“In the past year we've seen a lot of stabilization of WebRTC. You can now use it in production with a far greater degree of certainty. A lot of the real developments in the past year have been in things like the data channel, which will enable a whole new type of application," explained Peter Dunkley, Technical Director at Acision, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Leysin American School is an exclusive, private boarding school located in Leysin, Switzerland. Leysin selected an OpenStack-powered, private cloud as a service to manage multiple applications and provide development environments for students across the institution. Seeking to meet rigid data sovereignty and data integrity requirements while offering flexible, on-demand cloud resources to users, Leysin identified OpenStack as the clear choice to round out the school's cloud strategy. Additional...
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover ...
SYS-CON Media announced today that Aruna Ravichandran, VP of Marketing, Application Performance Management and DevOps at CA Technologies, has joined DevOps Journal’s authors. DevOps Journal is focused on this critical enterprise IT topic in the world of cloud computing. DevOps Journal brings valuable information to DevOps professionals who are transforming the way enterprise IT is done. Aruna's inaugural article "Four Essential Cultural Hacks for DevOps Newbies" discusses how to demonstrate the...
"Our premise is Docker is not enough. That's not a bad thing - we actually love Docker. At ActiveState all our products are based on open source technology and Docker is an up-and-coming piece of open source technology," explained Bart Copeland, President & CEO of ActiveState Software, in this SYS-CON.tv interview at DevOps Summit at Cloud Expo®, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"BSQUARE is in the business of selling software solutions for smart connected devices. It's obvious that IoT has moved from being a technology to being a fundamental part of business, and in the last 18 months people have said let's figure out how to do it and let's put some focus on it, " explained Dave Wagstaff, VP & Chief Architect, at BSQUARE Corporation, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
“DevOps is really about the business. The business is under pressure today, competitively in the marketplace to respond to the expectations of the customer. The business is driving IT and the problem is that IT isn't responding fast enough," explained Mark Levy, Senior Product Marketing Manager at Serena Software, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The move in recent years to cloud computing services and architectures has added significant pace to the application development and deployment environment. When enterprise IT can spin up large computing instances in just minutes, developers can also design and deploy in small time frames that were unimaginable a few years ago. The consequent move toward lean, agile, and fast development leads to the need for the development and operations sides to work very closely together. Thus, DevOps become...

ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ --  IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's

SYS-CON Events announced today that AIC, a leading provider of OEM/ODM server and storage solutions, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. AIC is a leading provider of both standard OTS, off-the-shelf, and OEM/ODM server and storage solutions. With expert in-house design capabilities, validation, manufacturing and production, AIC's broad selection of products are highly flexible and are conf...
SYS-CON Events announced today that IDenticard will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. IDenticard™ is the security division of Brady Corp (NYSE: BRC), a $1.5 billion manufacturer of identification products. We have small-company values with the strength and stability of a major corporation. IDenticard offers local sales, support and service to our customers across the United States and Canada...